Obesity is in the eye of the b...

India Blooms News Service

New York, May 24 (IBNS): Doctors have a specific definition of what it means to be overweight or obese, but in the social world, gender, race and generation matter a lot for whether people are judged as “thin enough” or “too fat,” according to a new Cornell University study.

Common sweetener in low-cal foods also a marker for weight gain, ...
New York, May 24 (IBNS): A new study has identified the sugar alcohol erythritol as a biomarker for increasing fat mass. In contrast to previous assumptions and research, erythritol can be metabolized by, and even produced in, the human body.
Chocolate bars can potentially reduce heart conditions, study fin...
London, May 24 (IBNS): Six bars of chocolate a week can reduce a person's heart condition by a quarter, a new study by Harvard University suggested.
Cognizant introduces healthcare administration platform powered b...
New York, May 22 (IBNS): Cognizant on Monday announced the launch of the TriZetto Healthcare Cloud Solution, a new secure, compliant managed services platform for healthcare payers of any size, powered by Microsoft Azure.
Over 100 cancer centers come together for the 7th National Cancer...
Mumbai, May 22 (IBNS): The National Cancer Grid (NCG), with the support of Tata Trusts, has announced a major initiative of facilitating a high bandwidth, secure and private network through which cancer care centres around the country can interact directly with other centres, thus enabling inter-centre knowledge sharing and providing access to multiple solutions like Virtual Tumor Board, Digital Nerve Centre and many more, an official release stated.
Yoga contributes to human happiness, says Yoga Day Canada chairma...
Toronto, May 21 (IBNS): The popularity of Yoga is rising all over the world in recent times and Canada is no exception.
Conjugate drug extends survival in patients with advanced HER2-po...
New York, May 19 (IBNS): Women with HER2-positive breast cancer that worsened after previous treatment, survived significantly longer, on average, with a combination antibody/chemotherapy drug than with other treatments, an international phase 3 clinical trial led by researchers at Dana-Farber Cancer Institute and in Belgium has found.
Study finds genetic difference in prostate cancer in African-Amer...
New York, May 19 (IBNS): A new genomic study has identified prostate cancer mutations that may be more common in men of African-American background and which might be a step toward explaining why the disease is more prevalent and deadly in that minority group, says a report from Dana-Farber Cancer Institute.
Web Analytics